Evidence for the Control of Aggrecanases by Insulin and Glucose in Alzheimer's Disease

Akyol S., Ugurcu V., Cakmak O., Altuntas A., Yukselten Y., Akyol O., ...Daha Fazla

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, cilt.24, sa.4, ss.323-332, 2014 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 24 Sayı: 4
  • Basım Tarihi: 2014
  • Doi Numarası: 10.5455/bcp.20140905124459
  • Dergi Adı: KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.323-332
  • Anahtar Kelimeler: ADAMTS5, IL-33, NF kappa B, diabetes, hyperglycemia, Alzheimer's disease, matrix degradation, AMYLOID PRECURSOR PROTEIN, CENTRAL-NERVOUS-SYSTEM, NF-KAPPA-B, DEGRADING ENZYME, DIABETES-MELLITUS, BETA-PROTEIN, POSTNATAL-DEVELOPMENT, CONVERTING ENZYME, IN-VIVO, BRAIN
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective: Alzheimer's disease (AD) is a progressive and irreversible central nervous system disease, which slowly destroys cognitive skills and memory, and eventually even the ability to handle the simplest tasks. The initiation and progression of AD is a poorly understood complex process. Here, we have investigated possible biological mechanisms that could be responsible for the increased risk for diminished brain function associated with diabetes in AD.